immatics biotechnologies - active against cancer « cancer-vaccine

(Klicks: 241;Website hinzugefügt: Feb 8, 2014, cancer-vaccine)

immatics is a private biopharmaceutical company based in Tuebingen, Germany. We are focused on the discovery and development of innovative active immunotherapies against cancer. Our proprietary technology allows us to identify tumor-associated peptide

cancer vaccine tumor vaccine anti-cancer vaccine anti-tumor vaccine peptide vaccine multi-peptide vaccine immunogenic peptide cancer-specific antigen